Joseph P. Lyssikatos - CHIEF SCIENTIFIC OFFICER at Enliven Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Stock Symbol
ELVN on Nasdaq
All Insider Reports
All Insider Reports

Joseph P. Lyssikatos - trading volume in the past year for Enliven Therapeutics, Inc.

Holdings reported by Joseph P. Lyssikatos for Enliven Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.09M $30M $27.56 Jul 31, 2024 Indirect
Stock Option (right to buy) 207K May 29, 2024 Direct Common Stock

Transactions reported by Joseph P. Lyssikatos for Enliven Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership